These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35905782)

  • 1. In-silico approach as a tool for selection of excipients for safer amphotericin B nanoformulations.
    Todke PA; Devarajan PV
    J Control Release; 2022 Sep; 349():756-764. PubMed ID: 35905782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Safety and Efficacy by Altering the Toxic Aggregated State of Amphotericin B in Lipidic Nanoformulations.
    Das S; Devarajan PV
    Mol Pharm; 2020 Jun; 17(6):2186-2195. PubMed ID: 32324420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B.
    Thanki K; Prajapati R; Sangamwar AT; Jain S
    Int J Pharm; 2018 Jun; 544(1):1-13. PubMed ID: 29635057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide).
    Lavasanifar A; Samuel J; Kwon GS
    J Control Release; 2002 Feb; 79(1-3):165-72. PubMed ID: 11853928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles.
    Yu BG; Okano T; Kataoka K; Sardari S; Kwon GS
    J Control Release; 1998 Dec; 56(1-3):285-91. PubMed ID: 9801451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aggregation state on the toxicity of different amphotericin B preparations.
    Espada R; Valdespina S; Alfonso C; Rivas G; Ballesteros MP; Torrado JJ
    Int J Pharm; 2008 Sep; 361(1-2):64-9. PubMed ID: 18599228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular localization and state of amphotericin B in PEG liposomes.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 1999 Dec; 193(1):97-106. PubMed ID: 10581426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B.
    Diezi TA; Kwon G
    Pharm Res; 2012 Jul; 29(7):1737-44. PubMed ID: 22130733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.
    Adams ML; Andes DR; Kwon GS
    Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembling, supramolecular chemistry and pharmacology of amphotericin B: Poly-aggregates, oligomers and monomers.
    Fernández-García R; Muñoz-García JC; Wallace M; Fabian L; González-Burgos E; Gómez-Serranillos MP; Raposo R; Bolás-Fernández F; Ballesteros MP; Healy AM; Khimyak YZ; Serrano DR
    J Control Release; 2022 Jan; 341():716-732. PubMed ID: 34933052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B.
    Yu BG; Okano T; Kataoka K; Kwon G
    J Control Release; 1998 Apr; 53(1-3):131-6. PubMed ID: 9741920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically Safe Nanomicelles of Amphotericin B With Lipids: Nuclear Magnetic Resonance and Molecular Docking Approach.
    Usman F; Ul-Haq Z; Khalil R; Tinpun K; Srichana T
    J Pharm Sci; 2017 Dec; 106(12):3574-3582. PubMed ID: 28847478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
    Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
    Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization of the interaction of the polyene antibiotic Amphotericin B with DODAB bicelles and vesicles.
    Oliveira TR; Benatti CR; Lamy MT
    Biochim Biophys Acta; 2011 Nov; 1808(11):2629-37. PubMed ID: 21839723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length.
    Adams ML; Kwon GS
    J Control Release; 2003 Feb; 87(1-3):23-32. PubMed ID: 12618020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A photophysical study on the role of bile salt hydrophobicity in solubilizing amphotericin B aggregates.
    Selvam S; Andrews ME; Mishra AK
    J Pharm Sci; 2009 Nov; 98(11):4153-60. PubMed ID: 19283765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
    Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
    Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.
    Burgess BL; He Y; Baker MM; Luo B; Carroll SF; Forte TM; Oda MN
    Int J Nanomedicine; 2013; 8():4733-43. PubMed ID: 24379661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward understanding of toxic side effects of a polyene antibiotic amphotericin B: fluorescence spectroscopy reveals widespread formation of the specific supramolecular structures of the drug.
    Wasko P; Luchowski R; Tutaj K; Grudzinski W; Adamkiewicz P; Gruszecki WI
    Mol Pharm; 2012 May; 9(5):1511-20. PubMed ID: 22506900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.